JP2024534801A5 - - Google Patents
Info
- Publication number
- JP2024534801A5 JP2024534801A5 JP2024510239A JP2024510239A JP2024534801A5 JP 2024534801 A5 JP2024534801 A5 JP 2024534801A5 JP 2024510239 A JP2024510239 A JP 2024510239A JP 2024510239 A JP2024510239 A JP 2024510239A JP 2024534801 A5 JP2024534801 A5 JP 2024534801A5
- Authority
- JP
- Japan
- Prior art keywords
- heterocyclylalkyl
- alkyl
- heteroaryl
- aryl
- cycloalkyl
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202163235543P | 2021-08-20 | 2021-08-20 | |
| US63/235,543 | 2021-08-20 | ||
| US202163289025P | 2021-12-13 | 2021-12-13 | |
| US63/289,025 | 2021-12-13 | ||
| PCT/US2022/040922 WO2023023347A1 (en) | 2021-08-20 | 2022-08-19 | Prodrugs and derivatives of psilocin and uses thereof |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2024534801A JP2024534801A (ja) | 2024-09-26 |
| JP2024534801A5 true JP2024534801A5 (enExample) | 2025-08-25 |
Family
ID=85241100
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024510239A Pending JP2024534801A (ja) | 2021-08-20 | 2022-08-19 | サイロシンのプロドラッグ及び誘導体ならびにその使用 |
Country Status (8)
| Country | Link |
|---|---|
| US (1) | US20250011344A1 (enExample) |
| EP (1) | EP4387608A4 (enExample) |
| JP (1) | JP2024534801A (enExample) |
| KR (1) | KR20240065084A (enExample) |
| AU (1) | AU2022328556A1 (enExample) |
| CA (1) | CA3229591A1 (enExample) |
| TW (1) | TW202315863A (enExample) |
| WO (1) | WO2023023347A1 (enExample) |
Families Citing this family (15)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU2021328726A1 (en) * | 2020-08-21 | 2023-03-02 | Compass Pathfinder Limited | Novel psilocin derivatives having prodrug properties |
| WO2022120181A1 (en) * | 2020-12-03 | 2022-06-09 | Mydecine Innovations Group Inc. | Novel psilocin analog compositions and methods of synthesizing the same |
| AU2022309017A1 (en) | 2021-07-07 | 2024-01-25 | Terran Biosciences Inc. | N,n-dimethyltryptamine and related psychedlics and uses thereof |
| WO2023086962A1 (en) | 2021-11-12 | 2023-05-19 | Terran Biosciences Inc. | Psilocybin and o-acetylpsilocin, salts and solid state forms thereof |
| JP2025502615A (ja) | 2021-12-15 | 2025-01-28 | デリックス セラピューティクス，インク． | フェノキシおよびベンジルオキシ置換サイコプラストゲンならびにその使用 |
| WO2023168023A1 (en) | 2022-03-04 | 2023-09-07 | Reset Pharmaceuticals, Inc. | Co-crystals or salts comprising psilocin |
| EP4493541A4 (en) * | 2022-03-18 | 2026-02-25 | Enveric Biosciences Canada Inc | TRYPTAMINE DERIVATIVES SUBSTITUTED BY C4-CARBOXYLIC ACID AND METHODS OF USE |
| US12065404B2 (en) | 2022-03-18 | 2024-08-20 | Enveric Biosciences Canada Inc. | C4-carboxylic acid-substituted tryptamine derivatives and methods of using |
| AU2023235712A1 (en) * | 2022-03-18 | 2024-11-07 | Enveric Biosciences Canada Inc. | C4-substituted tryptamine derivatives and methods of using |
| CA3267605A1 (en) * | 2022-09-12 | 2024-03-21 | Bionxt Solutions Inc. | PSILOCIN DERIVATIVES BASED ON AMINO ACIDS AND CARBOHYDRATES |
| WO2024108195A1 (en) | 2022-11-17 | 2024-05-23 | Remedi, Inc. | Combinations of monoamine oxidase inhibitors and serotonin receptor agonists and their therapeutic use |
| US20240269113A1 (en) * | 2023-01-24 | 2024-08-15 | Compass Pathfinder Limited | 3-(2-(DIMETHYLAMINO)ETHYL)-1H-INDOL-4-yl DERIVATIVES |
| TW202525777A (zh) * | 2023-08-25 | 2025-07-01 | 英商康派斯開拓者公司 | ３－（２－（二甲基胺基）乙基）－１ｈ－吲哚－４－基衍生物 |
| EP4592276A1 (en) | 2024-01-29 | 2025-07-30 | Universität Heidelberg | Novel acyloxymethyl prodrugs of psilocin and related 4-hydroxytryptamines obtained by an efficient synthetic approach |
| CN120329323B (zh) * | 2025-04-16 | 2026-01-13 | 黄冈鲁班药业股份有限公司 | 一种头孢吡普酯侧链的制备方法及应用 |
Family Cites Families (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3075992A (en) * | 1958-09-12 | 1963-01-29 | Sandoz Ltd | Esters of indoles |
| US20180021326A1 (en) * | 2016-07-23 | 2018-01-25 | Paul Edward Stamets | Compositions and methods for enhancing neuroregeneration and cognition by combining mushroom extracts containing active ingredients psilocin or psilocybin with erinacines or hericenones enhanced with niacin |
| US20190142851A1 (en) * | 2017-11-16 | 2019-05-16 | CaaMTech, LLC | Compositions comprising a psilocybin derivative and a cannabinoid |
| KR102316445B1 (ko) * | 2019-11-29 | 2021-10-26 | 씨제이제일제당 주식회사 | 신규 세린 프로테아제 변이체 |
| MX2022009527A (es) * | 2020-02-04 | 2022-11-16 | Mindset Pharma Inc | Derivados de la psilocina como agentes psicodelicos serotoninergicos para el tratamiento de trastornos del snc. |
| IL297861A (en) * | 2020-05-08 | 2023-01-01 | Psilera Inc | Novel compositions of matter and pharmaceutical compositions |
| DK4172145T3 (da) * | 2020-06-30 | 2026-07-20 | Reunion Neuroscience Inc | Tryptamin-prodrugs som serotonin-receptor-aktivatorer til behandling af f.eks. depression |
| AU2021328726A1 (en) * | 2020-08-21 | 2023-03-02 | Compass Pathfinder Limited | Novel psilocin derivatives having prodrug properties |
| WO2022120181A1 (en) * | 2020-12-03 | 2022-06-09 | Mydecine Innovations Group Inc. | Novel psilocin analog compositions and methods of synthesizing the same |
| IL309210A (en) * | 2021-06-09 | 2024-02-01 | Atai Therapeutics Inc | Parent drugs and conjugates of dimethyltryptamine |
-
2022
- 2022-08-19 KR KR1020247008856A patent/KR20240065084A/ko active Pending
- 2022-08-19 WO PCT/US2022/040922 patent/WO2023023347A1/en not_active Ceased
- 2022-08-19 AU AU2022328556A patent/AU2022328556A1/en not_active Abandoned
- 2022-08-19 JP JP2024510239A patent/JP2024534801A/ja active Pending
- 2022-08-19 TW TW111131397A patent/TW202315863A/zh unknown
- 2022-08-19 CA CA3229591A patent/CA3229591A1/en active Pending
- 2022-08-19 US US18/684,970 patent/US20250011344A1/en not_active Abandoned
- 2022-08-19 EP EP22859231.7A patent/EP4387608A4/en active Pending